Jack A. Khattar, President, CEO at SUPERNUS PHARMACEUTICALS, INC. (SUPN), sold 26,788 shares at $35.05 ($942K) on 2022-11-23, disclosed to the SEC on 2022-11-28.
Open-market sale of $942k SUPN by President, CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.05 | 2,259 | $79K | 8.4% |
| 2 | $35.05 | 2,259 | $79K | 8.4% |
| 3 | $35.18 | 11,135 | $392K | 41.6% |
| 4 | $35.18 | 11,135 | $392K | 41.6% |
| Total | $35.16 avg | 26,788 | $942K | 100% |
| Filing → |
| SUPN | SELL | 2025-10-03 | $183K | — | Filing → |
| SUPN | SELL | 2025-10-02 | $3.9M | — | Filing → |
| SUPN | SELL | 2025-10-01 | $414K | — | Filing → |